Vyluma Inc. Launches With Robust Opthalmic Portfolio, Leading With A Pharmaceutical Treatment In Phase III For Myopia

BRIDGEWATER, N.J., May 25, 2021 -- (Healthcare Sales & Marketing Network) -- Vyluma Inc. announces its establishment as a wholly owned subsidiary of Nevakar Inc., focusing on pharmaceutical ophthalmic solutions. The robust pipeline of novel therapies is l... Biopharmaceuticals, Ophthalmology Vyluma , Nevakar, myopia
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news